New Form 8-K - LivaNova PLC Filed: 2025-09-04 AccNo: 0001639691-25-000120 Size: 166 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
LivaNova Appoints Donald Zurbay as a New Director
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX,“Scilex”), and Denali Capital Acquisition Corp. Announce Approval from Denali’s Shareholders of the Previously Announced Business Combination
Dyadic to Present at Investor Conferences and BPI East
Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients
Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment
BioCardia CEO Peter Altman to Present at the H. C. Wainwright 27th Annual Global Investment Conference in New York City September 8-10, 2025
Xtant Medical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
NeuroSense Therapeutics Announces $500,000 Private Placement at Premium to Market Price
NeuroSense Therapeutics Announces $500,000 Private Placement at Premium to Market Price
Owlet Baby Care Inc. - Owlet Extends Global Reach with Launch of Medically-Certified Dream Sock™ to South Africa
Owlet Extends Global Reach with Launch of Medically-Certified Dream Sock™ to South Africa